FDA Warning Letter — LCC Ltd.

Case 657336 — FEI 3007255059

The FDA took a Warning Letter action against LCC Ltd. on August 3, 2023 (Eumseong, South Korea). The action was issued by CDER and concerns drugs products. This facility has 2 recent FDA inspections on record.

Action Details

Facility
LCC Ltd.
Date
August 3, 2023
Fiscal Year
2023
Product Type
Drugs
Center
CDER
Location
Eumseong (South Korea)